Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-02-14−3,600→ 61,823 totalExercise: $4.31Exp: 2027-08-20→ Common Stock (3,600 underlying) - Exercise/Conversion
Common Stock
2022-02-14$4.31/sh+3,600$15,516→ 106,461 total
Footnotes (1)
- [F1]This stock option was granted on 08/21/2017 and is fully vested.